SCHEMBL1128910

SCHEMBL1128910

c1ccc2cc3c(cc2c1)c1c(c2ccccc23)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 3/20 0.42
HIF1A Q16665 1/20 0.42
CYP1B1 Q16678 1/20 0.42
HPRT1 P00492 4/20 0.40
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
TRPM4 Q8TD43 1/20 0.38
CYP2A6 P11509 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP1A2 P05177 1/20 0.37
THRB P10828 1/20 0.37
HPGD P15428 1/20 0.37
NQO1 P15559 1/20 0.37
PI4KA P42356 1/20 0.35
PI4K2B Q8TCG2 1/20 0.35
PI4K2A Q9BTU6 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
PTGES O14684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzo[B]Triphenylene SCHEMBL29628013 0.82 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
Benzo[B]Triphenylene SCHEMBL29374595 0.82 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
SCHEMBL5555424 0.82 GPR84 (0.41) ALDH1A1HSD17B10HPRT1CYP2A6TSHR
SCHEMBL4855544 0.82 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
Benzo[B]Triphenylene SCHEMBL71635 0.82 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
Benzo[B]Triphenylene SCHEMBL17537048 0.79 ALDH1A1 (0.55) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
SCHEMBL415471 0.79 ALDH1A1 (0.55) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
SCHEMBL14877458 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
SCHEMBL711515 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1
SCHEMBL55388 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2283112-B1 COMPOSITIONS COMPRISING PRFA*MUTANT LISTERIA AND METHODS OF USE THEREOF ADURO BIOTECH (US) 2016-10-12 EP disclosed
US-20110287055-A1 COMPOSITIONS COMPRISING PRFA* MUTANT LISTERIA AND MEHTODS OF USE THEREOF ADURO BIOTECH (US) 2011-11-24 US disclosed
US-7927606-B2 Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods using the modified microbes for the activation antigens ADURO BIOTECH (US) 2011-04-19 US disclosed
EP-2283112-A1 COMPOSITIONS COMPRISING PRFA*MUTANT LISTERIA AND METHODS OF USE THEREOF Aduro Biotech (US) 2011-02-16 EP disclosed
US-7833775-B2 Modified free-living microbes, vaccine compositions and methods of use thereof ADURO BIOTECH (US) 2010-11-16 US disclosed
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed
US-7695725-B2 Modified free-living microbes, vaccine compositions and methods of use thereof ADURO BIOTECH (US) 2010-04-13 US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 WO disclosed
US-20100068230-A1 MODIFIED FREE-LIVING MICROBES, VACCINE COMPOSITIONS AND METHODS OF USE THEREOF CHINOOK THERAPEUTICS, INC. 2010-03-18 US disclosed
WO-2009143085-A1 COMPOSITIONS COMPRISING PRFA*MUTANT LISTERIA AND METHODS OF USE THEREOF ANZA THERAPEUTICS, INC. (US) 2009-11-26 WO disclosed
EP-0804074-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS Cerus Corporation (US) 1997-11-05 EP disclosed
EP-0773716-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS Cerus Corporation (US) 1997-05-21 EP disclosed
WO-1996039818-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS CERUS CORPORATION (US) 1996-12-19 WO disclosed
US-5559250-A 5-/N,N-BIS/2-CHLOROETHYL/AMINO/METHYL-8-METHOXYPSORALEN STERITECH, INC. (US) 1996-09-24 US disclosed
WO-1996014737-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS CERUS CORPORATION (US) 1996-05-23 WO disclosed
WO-1993010266-A1 DEVICE AND METHOD FOR DETECTION OF COMPOUNDS WHICH INTERCALATE WITH NUCLEIC ACIDS THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) 1993-05-27 WO disclosed
US-4968602-A DIAGNOSIS OF GENETIC DISORDERS MOLECULAR DIAGNOSTICS, INC. (US) 1990-11-06 US disclosed
US-4959309-A Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays MOLECULAR DIAGNOSTICS, INC. (US) 1990-09-25 US disclosed
EP-0187332-B1 PHOTOCHEMICAL METHOD OF LABELLING NUCLEIC ACIDS FOR DETECTION IN HYBRIDIZATION ASSAYS MOLECULAR DIAGNOSTICS, INC. (US) 1989-02-01 EP disclosed
US-4563417-A MEDICAL DIAGNOSIS MILES LABORATORIES, INC. (US) 1986-01-07 US disclosed